FunctionalKRASmutations and a potential role for PI3K/AKT activation in Wilms tumors-Reference-Cited by-同舟云学术

FunctionalKRASmutations and a potential role for PI3K/AKT activation in Wilms tumors

Published:2017-03-15 Issue:4 Volume:11 Page:405-421
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Polosukhina Dina¹,Love Harold D.¹,Correa Hernan²,Su Zengliu³,Dahlman Kimberly B.³⁴,Pao William³⁵,Moses Harold L.²³⁴⁵,Arteaga Carlos L.³⁴⁵,Lovvorn Harold N.⁶,Zent Roy⁷,Clark Peter E.¹³

Affiliation:

1. Department of Urologic Surgery; Vanderbilt University Medical Center; Nashville TN USA

2. Department of Pathology, Microbiology & Immunology; Vanderbilt University Medical Center; Nashville TN USA

3. Vanderbilt-Ingram Cancer Center; Nashville TN USA

4. Department of Cancer Biology; Vanderbilt University Medical Center; Nashville TN USA

5. Department of Medicine (Hematology-Oncology); Vanderbilt University Medical Center; Nashville TN USA

6. Department of Pediatric Surgery; Vanderbilt University Medical Center; Nashville TN USA

7. Department of Medicine, Nephrology & Cancer Biology Division; Vanderbilt University Medical Center; Nashville TN USA

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference63 articles.

1. Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors;Ando;Cancer Sci,2014

2. A phase Ib dose-escalation study of the oral Pan-PI3K Inhibitor Buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor Trametinib (GSK1120212) in patients with selected advanced solid tumors;Bedard;Clin Cancer Res,2015

3. Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors;Bendell;J Clin Oncol,2012

4. Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition;Bielen;Proc Natl Acad Sci U S A,2012

5. Synergistic activation of the murine gastrin promoter by oncogenic Ras and beta-catenin involves SMAD recruitment;Chakladar;Biochem Biophys Res Commun,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Circular RNA in the Pathogenesis of Chemotherapy-Induced Cardiotoxicity in Cancer Patients: Focus on the Pathogenesis and Future Perspective;Cardiovascular Toxicology;2024-08-19

2. Nephroblastoma-specific dysregulated gene SNHG15 with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation;Discover Oncology;2024-03-25

3. Karanjin, A Promising Bioactive Compound Possessing Anti-cancer Activity against Experimental Model of Non-small Cell Lung Cancer Cells;Anti-Cancer Agents in Medicinal Chemistry;2023-11-06

4. ZSTK474 Targeting PIK3R3 Inhibits the Wilms' Tumor through G0 / G1 Phase Arrest;2023-10-24

5. Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition;JCI Insight;2023-05-08